Oscient Pharmaceuticals Corp. (OSCI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tara Cobble who wrote ()	2/24/2000 3:25:00 PM
From: T A P	Read Replies (2) of 1154

GENE NEWS ~ BUY RATING ~ Also "On air pick on CNBC!! More Brokerages are now starting to recommend and offer GENE to clients as an investment. This was the key factor that T AP thought had been seperating GENE from CRA as GENE only had one Brokerage (Oppenheimer) behind it compared to CRA having 5. T A P believes GENE has just begun to get noticed and more Initiated coverage will follow as GENE market cap is still well under $1 billion compared to CRA well over $11 billion. GENE balance sheet also is much better than CRA and GENE could be profitable very soon which is a big plus for a bio-tech company! M.H. Meyerson & Co., Inc. Initiates Coverage of Genome Therapeutics Corporation (Nasdaq: GENE) With a 'Buy' Rating JERSEY CITY, N.J., Feb. 24 /PRNewswire/ -- M.H. Meyerson & Co., Inc. (Nasdaq: MHMY - news) announced coverage has been initiated on Genome Therapeutics Corporation (Nasdaq: GENE - news) with a BUY RATING. For more information contact Andrew H. Scott, Director of Research at 201-459-9440 or 800-422-4114; Web site: mhmeyerson.com, SOURCE: M.H. Meyerson & Co., Inc. GENE was also "on -air pick" by Brian Clifford, vice president and portfolio manager at SunAmerica Asset Management, who was Thursday?s guest on Taking Stock during Market Watch on CNBC. www.cnbc.com/commentary/commentary_full_story_stocks.asp?StoryID=13476 T A P has taken a position in GENE on the open market and is not compensated in any way by any company mentioned! All information can not be guaranteed but is believed accurate and is for purpose of research and is not a solicitation to buy any security and doing so will be done at your own risk. For more information on GENE see other posts on this and T A P General Topic & Internet/Biotech message boards. To join T A P free go to T A P profile for url

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next